FDA Inspection
DIAGASTDIAGAST – FDA Inspection, Mar 21, 2019
Record Details
This FDA Inspection record concerns DIAGAST, with an inspection on March 21, 2019, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · 2d8b54ee-8267-42cd-aac2-afaf3edaeee8
Inspection Facts
- Inspection number
- 1087957
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of DIAGAST
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 19, 2024 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 21, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 17, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 8, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 16, 2009 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for DIAGAST
- FDA Inspection 1236304 - 2024-04-19
- FDA Inspection 1012901 - 2017-02-21
- FDA Inspection 927715 - 2015-03-17
- FDA Inspection 715544 - 2011-03-08
- FDA Inspection 594229 - 2009-01-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.